ArticleBMC public health2026
Associations between social determinants and poor hypertension treatment adherence among middle-aged and older people in rural China: a hospital-based case‒control study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTreatment adherence is a major challenge in hypertension management, particularly given the growing aging issue and burden of chronic diseases in China. Middle-aged and older adults with hypertension in rural China face a greater risk of poor adherence because of health care disparities and limited primary care support. This study aimed to determine the factors associated with treatment adherence among middle-aged and older adults with hypertension in rural China.
methodsA hospital-based case–control study was conducted to gather information among hypertensive patients in Daqiao Town, China. Treatment adherence was assessed using the Hill-Bone Compliance to High Blood Pressure Therapy (HBCHBPT) scale, with cases defined as patients with poor adherence (score < 48) and controls defined as those with good adherence (score ≥ 48). Data were collected using a structured questionnaire, and stepwise logistic regression was used to identify factors associated with poor adherence.
resultsA total of 287 patients with hypertension (96 cases and 191 controls) were included. Overall, 56.1% were aged 40–65 years, 48.4% were male, and 54.7% were employed. Poor antihypertensive treatment adherence was significantly associated with being employed (AOR = 4.15, 95% CI = 1.63–10.56), taking ≥ 3 medicines (AOR = 3.67, 95% CI = 1.45–9.30), having ≥ 3 other chronic diseases (AOR = 2.66, 95% CI = 1.18–5.99), infrequent blood pressure measurement (AOR = 3.41, 95% CI = 1.00–11.66), attending follow-up with companions or alone (AOR = 9.79, 95% CI = 4.01–23.90), poor self-rated blood pressure control (AOR = 3.32, 95% CI = 1.12–9.78), insufficient health literacy (AOR = 5.84, 95% CI = 2.60–13.08), low self-efficacy (AOR = 6.11, 95% CI = 2.54–14.67), and low perceived social support (AOR = 6.11, 95% CI = 2.42–13.67).
conclusionPoor adherence reflects the combined effects of treatment complexity, primary health care, and psychosocial factors. Blood pressure monitoring, village doctor home visits, chronic disease management, self-rated blood pressure assessment, and targeted health education with psychosocial support would help to improve long-term adherence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.